The Ministry of Health and Family Welfare vide notification dated 27th January, 2020, issued amendment to the Drugs and Cosmetics Act, 1940 by which the Oxytocin reference standards is permitted to be imported exclusively for the purpose of test and analysis.
The Central Government in its earlier notification dated 24th April 2018 has prohibited the import of the Oxytocin in public interest, considering the harmful effects of Oxytocin and its formulation. Subsequent to the above-mentioned Notification, the Central Government received representations from various stakeholders to allow import of Oxytocin reference standards for the purpose of examination, test or analysis n reference standards is necessary exclusively for the purpose of examination, test or analysis before carrying out commercial manufacturing of the said drug .
Therefore through this notification, it permitted the import of Oxytocin reference standards to be exclusively for the purpose of examination, test or analysis before carrying out commercial manufacturing of the said drug.
Click here to read the Notification.
